Covered recipient · General Payments record
ANNAMARIE C LAMMENDOLA-MELONE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$1,188.09
- Reported across 56 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.18 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| SHIELD THERAPEUTICS INC | $53.93 | 1 |
| Abbott Laboratories | $47.36 | 2 |
| ABBVIE INC. | $39.04 | 2 |
| Lilly USA, LLC | $34.12 | 1 |
| DEXCOM, INC. | $34.03 | 1 |
| Novo Nordisk AS | $23.74 | 1 |
| GlaxoSmithKline, LLC. | $21.49 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.97 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240958836 | CMS |
| Abbott Laboratories | $23.39 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240969842 | CMS |
| ABBVIE INC. | $21.53 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202261842 | CMS |
| ABBVIE INC. | $17.51 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202261844 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.47 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225617271 | CMS |
| Dexcom, Inc. | $34.03 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250470624 | CMS |
| GlaxoSmithKline, LLC. | $21.49 | 04/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190383215 | CMS |
| Lilly USA, LLC | $34.12 | 07/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186522347 | CMS |
| Novo Nordisk Inc | $23.74 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189005445 | CMS |
| SHIELD THERAPEUTICS INC | $53.93 | 05/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249614240 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.